[Amplifying sequences in the Streptomyces coelicolor A3 (2) gene]. 1990

S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko

The unstable feature of ristomycin resistance in S. coelicolor A3 (2) was studied. It was shown that the frequency of ristomycin-resistant derivatives was high in both chloramphenicol sensitive mutants and their resistant revertants. The 15- and 20-kb DNA sequences capable of amplifying were detected in the chloramphenicol resistant revertants. In the genomes of the studied strains they were represented by 50 and 40 copies, respectively.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D002702 Chloramphenicol Resistance Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides. Chloramphenicol Resistances
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
February 1980, Molecular & general genetics : MGG,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
August 2005, Bioscience, biotechnology, and biochemistry,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
September 1976, Mutation research,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
February 1991, Molecular microbiology,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
March 1987, Journal of general microbiology,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
November 1974, Genetics,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
June 1995, Microbiology (Reading, England),
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
January 1984, Izvestiia Akademii nauk SSSR. Seriia biologicheskaia,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
November 1989, Molecular microbiology,
S A Zavorotnaia, and V A Fedorenko, and L I Starodubtseva, and V N Danilenko
September 1999, Journal of bacteriology,
Copied contents to your clipboard!